A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease1

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Immunology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.175.9.6226PMID 16237121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Vaccines

  2006cited by this paper
• Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.

  2005cited by this paper
• Suppressive oligonucleotides protect against collagen-induced arthritis in mice.

  2004cited by this paper
• Immunity to the Extracellular Domain of Nogo-A Modulates Experimental Autoimmune Encephalomyelitis1

  2004cited by this paper
• Immune Therapy for Autoimmune Diseases

  2004cited by this paper
• Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination.

  2004cited by this paper
• Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.

  2004cited by this paper
• The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

  2004cited by this paper
• An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems 1

  2003influential reference
• Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

  2003influential reference
• Do myelin-directed antibodies predict multiple sclerosis?

  2003cited by this paper
• DNA Fragments of the Human 60-kDa Heat Shock Protein (HSP60) Vaccinate Against Adjuvant Arthritis: Identification of a Regulatory HSP60 Peptide 1

  2003cited by this paper
• Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

  2003cited by this paper
• A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

  2003cited by this paper
• Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

  2003cited by this paper
• Suppressive DNA Vaccination in Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis Involves a T1-Biased Immune Response 1

  2003cited by this paper
• Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL‐4 increases safety

  2002cited by this paper
• Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice.

  2002cited by this paper
• Protein and peptide array analysis of autoimmune disease.

  2002cited by this paper
• Proteomics technologies for the study of autoimmune disease.

  2002cited by this paper
• Distinct Response of Human B Cell Subpopulations in Recognition of an Innate Immune Signal, CpG DNA

  2002cited by this paper
• Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides.

  2002cited by this paper
• Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway.

  2001influential reference
• Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice.

  2001cited by this paper
• DNA vaccines.

  2001cited by this paper
• Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice1

  2001cited by this paper
• Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection.

  2001cited by this paper
• Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis.

  2000cited by this paper
• DNA immunization to prevent autoimmune diabetes.

  1999cited by this paper
• Identification of autoantibodies associated with myelin damage in multiple sclerosis

  1999cited by this paper
• Autoimmune Disease: Modulation of T Cell Encoding a Self-Peptide Prevents Suppressive Immunization with DNA

  1999cited by this paper
• Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a.

  1999cited by this paper
• Gene vaccination: plasmid DNA is more than just a blueprint.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Vaccination with DNA Encoding an Immunodominant Myelin Basic Protein Peptide Targeted to Fc of Immunoglobulin G Suppresses Experimental Autoimmune Encephalomyelitis

  1998cited by this paper
• Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65.

  1997cited by this paper
• DNA vaccines for the treatment of autoimmune disease

  1997cited by this paper
• Strategies for preventing type I diabetes mellitus.

  1996cited by this paper
• Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity

  1996cited by this paper
• IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

  1996cited by this paper
• Autoimmune disease.

  1993cited by this paper
• More fun than a root canal.

  1993cited by this paper
• The T lymphocyte in experimental allergic encephalomyelitis.

  1990cited by this paper
• IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide.

  1988cited by this paper
• IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide.

  1988cited by this paper
• Regulation of IgG1 and IgE Production by Interleukin 4

  1988cited by this paper
• Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

  1987cited by this paper
• Regulation of B‐Lymphocyte Activation, Proliferation, and Differentiation

  1987cited by this paper
• Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response.

  1987cited by this paper
• Role of γ-interferon in antibody-producing responses

  1984cited by this paper
• Role of gamma-interferon in antibody-producing responses.

  1984cited by this paper
• Encephalomyelitis Experimental Autoimmune Suppressive Dna Vaccination in Cytokine Milieu Determine the Efficacy of Presence of Cpg Dna and the Local

  year unknowncited by this paper

• Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven Autoimmunity.

  2024cites this paper
• Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy.

  2024cites this paper
• Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis

  2022cites this paper
• Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors

  2022cites this paper
• Biophysical Properties of Self-Assembled Immune Signals Impact Signal Processing and the Nature of Regulatory Immune Function.

  2021cites this paper
• The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane

  2021cites this paper
• Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy.

  2021cites this paper
• Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis

  2020cites this paper
• Engineering release kinetics with polyelectrolyte multilayers to modulate TLR signaling and promote immune tolerance.

  2019cites this paper
• A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.

  2019cites this paper
• One Group's Historical Reflections on DNA Vaccine Development

  2018cites this paper
• Engineering Zwitterionic-switchable Chromatin-mimetic Nanoparticles for Immune Modulation

  2018cites this paper
• A Chromatin-Mimetic Nanomedicine for Therapeutic Tolerance Induction.

  2018cites this paper
• 10 Tolerance and Autoimmunity in Type 1 Diabetes

  2017cites this paper
• The Role of TGF-β in CTB-Insulin Regulated Human Dendritic Cell Tolerance

  2017cites this paper
• Engineering self-assembled materials to study and direct immune function

  2017cites this paper
• Lack of Efficacy of Liposomal Amphotericin B Against Acute and Chronic Trypanosoma cruzi Infection in Mice.

  2017cites this paper
• Polyplexes assembled from self-peptides and regulatory nucleic acids blunt toll-like receptor signaling to combat autoimmunity.

  2017cites this paper
• Antigen-specific immunotherapies in rheumatic diseases

  2017cites this paper
• Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.

  2016cites this paper
• Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific.

  2016cites this paper
• Regulation of human monocyte differentiation into m1- and m2-like macrophages

  2016cites this paper
• tructure , mechanism and therapeutic utility of immunosuppressive ligonucleotides

  2016cites this paper
• Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides.

  2016cites this paper
• Epitope Spreading in Autoimmune Diseases

  2015cites this paper
• Emerging immunopharmacological targets in multiple sclerosis.

  2015cites this paper
• Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.

  2014cites this paper
• Antigen-specific tolerization approaches in multiple sclerosis

  2014cites this paper
• Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9

  2013cites this paper
• Protective role of synthetic oligodeoxynucleotides expressing immunosuppressive TTAGGG motifs in concanavalin A-induced hepatitis.

  2013cites this paper
• Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.

  2013cites this paper
• A deep-blue OLED-based biochip for protein microarray fluorescence detection.

  2013cites this paper
• DERIVATION OF TOLEROGENIC THERAPEUTIC VACCINES FOR MOUSE MODELS OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

  2012cites this paper
• DNA-based vaccines for multiple sclerosis: current status and future directions.

  2012cites this paper
• Tolerance and Autoimmunity in Type 1 Diabetes

  2011cites this paper
• Inverse Vaccination to Silence Immunity to Myelin in Multiple Sclerosis

  2010cites this paper
• A GMCSF‐neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC

  2010cites this paper
• Treatment with a Toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice

  2010influential citation
• Mammalian Telomeric DNA Suppresses Endotoxin-induced Uveitis*

  2010cites this paper
• Inverse vaccination, the opposite of Jenner’s concept, for therapy of autoimmunity

  2010cites this paper
• DNA vaccines for autoimmune diseases

  2009cites this paper
• Recent advances in DNA vaccines for autoimmune diseases

  2009cites this paper
• Immunoregulatory activities of nanoparticle-forming oligodeoxynucleotides

  2009cites this paper
• A suppressive oligodeoxynucleotide inhibits ocular inflammation

  2009cites this paper
• Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

  2008cites this paper
• A DNA vaccine for multiple sclerosis

  2008cites this paper
• Vaccines for Multiple Sclerosis

  2008cites this paper
• Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

  2008cites this paper
• DETECTION OF AUTOANTIBODIES USING PROTEIN ARRAYS

  2007cites this paper
• Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

  2007cites this paper
• Multiple sclerosis: a complicated picture of autoimmunity

  2007cites this paper
• Periodontal Bacterial DNA Suppresses the Immune Response to Mutans Streptococcal Glucosyltransferase

  2007cites this paper
• Tolerizing DNA vaccines for autoimmune arthritis

  2006influential citation
• Peptide-based therapy for autoimmune diseases

  2006cites this paper
• Future of multiple sclerosis therapy: combining antigen-specific immunotherapy with strategies to promote myelin repair

  2006cites this paper
• Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.

  2006cites this paper
• Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and Peptides

  2005cites this paper
• One Group’s Historical Reflections on DNA Vaccine Development

  year unknowncites this paper